ATPase

ATPase

ATPase related products

Structure Cat No. Product Name CAS No. Product Description
V0180 (-)-Blebbistatin 856925-71-8 Blebbistatin is a potent, selective, reversible and cell-permeable small molecule inhibitor for non muscle myosin II ATPase with IC50 of around 2 μM in cell-free assays.
V2325 BRITE-338733 503105-88-2 BRITE-338733 is a novel and potent RecA ATPaseinhibitor(IC50= 4.7 µM).
V0191 BTB06584 219793-45-0 BTB06584 (BTB-06584; BTB 06584) is a novel, potent and IF1-dependent inhibitor of the mitochondrial F1 Fo-ATPase, acting by selectively inhibiting mitochondrial F1 Fo-ATPase activity without compromising ATP synthesis and to limit ischaemia-induced injury caused by reversal of the mitochondrial F1 Fo-ATPsynthase.
V8748 Bufalin 465-21-4 Bufalin is a novel and potent inhibitor of steroid receptor coactivator 3 (SRC-3) with anticancer,anti-inflammatory and antinociceptive activity.
V17787 CDN-1163 892711-75-0 CDN-1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA).
V2377 KM 91104 304481-60-5 KM-91104 is a novel and potent cell-permeable inhibitor of V-ATPase.
V25685 ML367 381168-77-0 ML367 is a novel andpotent inhibitor of ATPase family AAA domain-containing protein 5 (ATAD5) stabilization, it acts as a probe molecule that has low micromolar inhibitory activity.
V26869 Oleandrin 465-16-7 Oleandrin is a novel and potent cardiac glycoside.
V26870 Oleic acid 112-80-1 Oleic acid(also known as 9-cis-Octadecenoic acid; 9Z-Octadecenoic acid) is the most common and abundantmonounsaturatedfatty acid (FA), acting asaNa+/K+ATPaseactivator.
V6287 Ouabain (G-Strophanthin) 630-60-4 Ouabain (Ouabain Octahydrate; Acocantherine; G-Strophanthin),a cardiac steroid, is a novel, potent andselective Na+/K+, -ATPase inhibitor, which binds to α2 /α3 subunit with Ki of 41 nM/15 nM.
V6322 Oxytetracycline 79-57-2
V6079 Rhodamine 123 (RH-123; R-22420) 62669-70-9 Rhodamine 123 (RH123; R22420) is a fluorescent dye with λex of503 nm and λemof 527 nm.
V16014 Tegoprazan 942195-55-3 Tegoprazan, a novel and potent P-CAB (potassium-competitive acid blocker),is a next-generation therapeutics developed for the treatment of acid-related gastrointestinal diseases such as gastroesophageal reflux disease (GERD) and peptic ulcers, acting bycontroling gastric acid secretion and motility.
V9143 Thapsigargin 67526-95-8 Thapsigargin is a novel and potent non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) and an Endoplasmic Reticulum (ER) stress inducing agent.
Contact Us